Mary K Stone

Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma

F. Zhan, B. Barlogie, J. Shaughnessy, 2009, Molecular Cancer Therapeutics.